| pubmed-article:20192976 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20192976 | lifeskim:mentions | umls-concept:C0069676 | lld:lifeskim |
| pubmed-article:20192976 | lifeskim:mentions | umls-concept:C0151744 | lld:lifeskim |
| pubmed-article:20192976 | lifeskim:mentions | umls-concept:C1514475 | lld:lifeskim |
| pubmed-article:20192976 | lifeskim:mentions | umls-concept:C0205360 | lld:lifeskim |
| pubmed-article:20192976 | lifeskim:mentions | umls-concept:C0016441 | lld:lifeskim |
| pubmed-article:20192976 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:20192976 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:20192976 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20192976 | pubmed:dateCreated | 2010-5-25 | lld:pubmed |
| pubmed-article:20192976 | pubmed:abstractText | Osteopontin (OPN) is a glycoprotein, which may play a major role in the regulation of biological phenomena. Increased levels of OPN have been linked to the presence and to the severity of atherosclerosis. This study was undertaken to assess the prognostic significance of plasma OPN levels in patients with stable ischaemic heart disease (IHD). | lld:pubmed |
| pubmed-article:20192976 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20192976 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20192976 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20192976 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20192976 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20192976 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20192976 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:20192976 | pubmed:issn | 1365-2362 | lld:pubmed |
| pubmed-article:20192976 | pubmed:author | pubmed-author:IliodromitisE... | lld:pubmed |
| pubmed-article:20192976 | pubmed:author | pubmed-author:CapetanakiYas... | lld:pubmed |
| pubmed-article:20192976 | pubmed:author | pubmed-author:MavroidisMano... | lld:pubmed |
| pubmed-article:20192976 | pubmed:author | pubmed-author:KremastinosDi... | lld:pubmed |
| pubmed-article:20192976 | pubmed:author | pubmed-author:BoudoulasHari... | lld:pubmed |
| pubmed-article:20192976 | pubmed:author | pubmed-author:GeorgiadouPan... | lld:pubmed |
| pubmed-article:20192976 | pubmed:author | pubmed-author:VarounisChris... | lld:pubmed |
| pubmed-article:20192976 | pubmed:author | pubmed-author:KolokathisFot... | lld:pubmed |
| pubmed-article:20192976 | pubmed:author | pubmed-author:GizasVassilis... | lld:pubmed |
| pubmed-article:20192976 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20192976 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:20192976 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20192976 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20192976 | pubmed:pagination | 288-93 | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:meshHeading | pubmed-meshheading:20192976... | lld:pubmed |
| pubmed-article:20192976 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20192976 | pubmed:articleTitle | Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study. | lld:pubmed |
| pubmed-article:20192976 | pubmed:affiliation | Attikon University General Hospital, 1 Rimini Str., 12462 Athens, Greece. pg171@hlk.forthnet.gr | lld:pubmed |
| pubmed-article:20192976 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20192976 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
